Esperite N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 15 jun 2016 - 07:17

Statutaire naam Esperite N.V.

Titel Esperite N.V.: important recurrent financial improvements from Laboratory transfer and cost reduction program Galaxy

Bericht ESPERITE N.V. announces important recurrent financial improvements from Laboratory transfer and cost reduction program Galaxy 1.2 Millions euro saving per year starting June 2016 Zutphen, The Netherlands - 15 June 2016 An important cost saving and reorganisation program called Galaxy was announced by Esperite's CEO, Frederic Amar in 2014. The Galaxy project aims to centralize and optimize CryoSave's laboratory for Stem Cell processing in Switzerland. Main targets are to improve the efficiency, to reduce the transportation costs and to avoid the double costs of having two fully operational facilities in place.

Vorige register resultaat

Volgende register resultaat

Gerelateerde downloads

201606150000000002_ESPERITE PR GALAXY PROJECT.pdf (opens in a new window)

Datum laatste update: 14 maart 2026